Rilutek (riluzole) tablets in the U.S.

Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets in the U.S...probably soon in Canada.

This is the first drug approved for treating amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

ALS is a progressive, degenerative disease of the nerves. It leads to muscle weakness...paralysis...and eventually death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote